Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Aspirin in Prevention of Permanent Hemodialysis Catheter Thrombosis
IRCT20181128041785N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin in chronic kidney disease (CKD) and catheter-related thrombosis (CRT), sponsored by Ardabil University of Medical Sciences. Primary endpoint: Incidence of permanent hemodialysis catheter thrombosis. Started Nov 2018; status: completed.
02
Drugs
aspirin
03
Conditions
chronic kidney disease (CKD)catheter-related thrombosis (CRT)
Beyond the preview
Go deeper on IRCT20181128041785N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181128041785N1.